International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 289-296 , May 1999

Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation

Presented at the 80th Annual Meeting of the American Radium Society, Monte Carlo, Monaco, 1998.

  • Douglas W Arthur, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • Corresponding Author InformationReprint requests to: Douglas W. Arthur, M.D., Medical College of Virginia Hospitals of Virginia Commonwealth University, P.O. Box 980058, Richmond, VA 23298-0058
    • ,
  • Rupert K Schmidt-Ullrich, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Richard B Friedman, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • David E Wazer, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Lisa A Kachnic, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Cyrus Amir, PhD (.)

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Harry D Bear, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Mary Helen Hackney, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Thomas J Smith, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA
    • ,
  • Walter Lawrence Jr., M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU) Richmond, VA, USA

,Accepted 30 December 1998.

References 

  1. Arriagada R, Mouriesse H, Spielmann M, et al.  Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 1990;19:1207–1210
  2. Brun B, Otmezguine Y, Feuilhade F, et al.  Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 1988;61:1096–1103
  3. Buzdar AU, Montague ED, Barker JL, et al.  Management of inflammatory carcinoma of breast with combined modality approach - an update. Cancer. 1981;47:2537–2542
  4. Chu AM, Wood WC, Doucette JA. Inflammatory breast carcinoma treated by radical radiotherapy. Cancer. 1980;45:2730–2737
  5. Fastenberg NA, Buzdar AU, Montague ED, et al.  Management of inflammatory carcinoma of the breast. Am J Clin Oncol. 1985;8:134–141
  6. Fleming RY, Asmar L, Buzdar AU, et al.  Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol. 1997;4:452–461
  7. Hagelberg RS, Jolly PC, Anderson RP. Role of surgery in the treatment of inflammatory breast carcinoma. Am J Surg. 1984;148:125–131
  8. Knight CD, Martin JK, Welch JS, et al.  Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancer. Surgery. 1986;99:385–390
  9. Kuske RR. Diagnosis and management of inflammatory breast cancer. Semin Radiat Oncol. 1994;4:270–282
  10. Lamb CC, Eberlein TJ, Parker LM, et al.  Results of radical radiotherapy for inflammatory breast cancer. Am J Surg. 1991;162:236–242
  11. Morris DM. Mastectomy in the management of patients with inflammatory breast cancer. J Surg Oncol. 1983;23:255–258
  12. Perez CA, Fields JN, Fracasso PM, et al.  Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 1994;74:466–476
  13. Pisansky TM, Schaid DJ, Loprinzi CL, et al.  Inflammatory breast cancer: Integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol. 1992;15:376–387
  14. Radie-Keane K, Wazer DE, Schmidt-Ullrich R. Locoregional control of inflammatory carcinoma of the breast with accelerated superfractionated radiotherapy. Breast Dis. 1994;7:59–68
  15. Rouesse J, Friedman S, Sarrazin D, et al.  Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol. 1986;4:1765–1771
  16. Singletary SE, Ames FC, Buzdar AU. Management of inflammatory breast cancer. World J Surg. 1994;18:87–92
  17. Thomas F, Arriagada R, Spielmann M, et al.  Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy. Cancer. 1995;76:2286–2290
  18. Thoms WW, McNeese MD, Fletcher GH, et al.  Multimodality treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:739–745
  19. Fields JN, Perez CA, Kuske RR, et al.  Inflammatory carcinoma of the breast: Treatment results on 107 patients. Int J Radiat Oncol Biol Phys. 1989;17:249–255
  20. Schafer P, Alberto P, Forni M, et al.  Surgery as part of a combined modality approach for inflammatory breast carcinoma. Cancer. 1987;59:1063–1067
  21. Haagenson CD. Diseases of the breast. 2nd ed. Philadelphia: WB Saunders; 1971. p. 576–584.
  22. Camp E. Inflammatory carcinoma of the breast. Am J Surg. 1976;131:583–586
  23. Treves N. The inoperability of inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1959;109:240–242
  24. Koh EH, Buzdar AU, Ames FC, et al.  Inflammatory carcinoma of the breast: Results of a combined-modality approach – M.D. Anderson Cancer Center experience. Cancer Chemother Pharmacol. 1990;27:94–100
  25. Krutchik AN, Buzdar AU, Blumenschein GR, et al.  Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma. J Surg Oncol. 1979;11:325–332
  26. Sataloff DM, Mason BA, Prestipino AJ, et al.  Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome. J Am Coll Surg. 1995;180:297–304
  27. Maloisel F, Dufour P, Bergerat JP, et al.  Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer. 1990;65:851–855
  28. Sherry MM, Johnson DH, Page DL, et al.  Inflammatory carcinoma of the breast: Clinical review and summary of the Vanderbilt experience with multi-modality therapy. Am J Med. 1985;79:355–364
  29. Donegan WL, Padrta B. Combined therapy for inflammatory breast cancer. Arch Surg. 1990;125:578–582
  30. Burton GV, Cox EB, Leight GS, et al.  Inflammatory breast carcinoma: Effective multimodal approach. Arch Surg. 1987;122:1329–1332
  31. Ragaz J, Jackson SM, Ne N, et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  32. Overgaard M, Hanson PS, Overgaard J, et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  33. Fleming ID, Cooper JS, Henson DE; et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 171–180.
  34. Fields KK, Elfenbein GJ, Lazarus HM, et al.  Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over six days followed by autologous stem cell rescue: Toxicity profile. J Clin Oncol. 1995;13:323–332
  35. Fields KK, Zorsky PE, Hiemenz JW, et al.  Ifosfamide, carboplatin, and etoposide: A new regimen with a broad spectrum of activity. J Clin Oncol. 1994;12:544–552
  36. Hortobaygi GN, Singletary SE, McNeese MD. Treatment of locally advanced and inflammatory breast cancer. In:  Harris JR,  Lippman ME,  Morrow M,  Hellman S editor. Diseases of the breast. Philadelphia: Lippincott-Raven Publishers; 1996;p. 585–599

PII: S0360-3016(99)00019-X

International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 289-296 , May 1999

Article Tools

* Image Usage & Resolution